Global Brand Lead, Navtemadlin Oncology Launch & Strategy

Ipsen

Cambridge (MA)

On-site

USD 233,000 - 320,000

Full time

7 days ago

Be an early applicant

Application generator

Get a reply from this employer — a resume and cover letter tailored to exactly what they’re hiring for.

Get past ATS filters

Benefits offered by this job

401(k) with company contributions

Medical, dental and vision coverage

Life and disability insurance

Parental leave

Job summary

Ipsen seeks a Global Brand Lead, Hematology / Oncology for Navtemadlin to shape and deliver the brand strategy for a late-stage oncology asset. Based in the US, this senior leader will drive integrated branding, priorities, and cross-functional alignment for launch readiness and long-term value.

The ideal candidate has 15+ years in pharma with late-stage development and global launches, preferably in oncology/hematology, and MBA is a plus.

Qualifications

15+ years of pharma/biotech experience including global or regional marketing, brand strategy, asset strategy and launch leadership.
Demonstrated late-stage development, pre-launch, and global launch experience, including in the U.S.
Experience in oncology and hematology is preferred.
Proven ability to lead across Medical, Market Access, Regulatory, Development, and Commercial functions.

Responsibilities

Brand Strategy & Portfolio Leadership: Develop and execute the integrated brand strategy for Navtemadlin to maximize long-term asset value.
Launch & Growth Execution: Lead late-stage development commercialization planning and launch readiness activities for a Phase 3 oncology therapeutic, with a strong focus on US market requirements.
Cross-Functional Leadership: Lead and influence a global matrix team across Commercial, Medical, Market Access, Regulatory, Finance, Supply Chain, and other key functions.